PDS Biotechnology SG&A Expense (TTM) Insights

PDS Biotechnology Corp (PDSB)

2.95 -0.08 (-2.64%) USD | NASDAQ | Jul 02, 16:00

2.955 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2024	15.10M
December 31, 2023	15.28M
September 30, 2023	15.01M
June 30, 2023	13.86M
March 31, 2023	12.50M
December 31, 2022	12.24M
September 30, 2022	12.51M
June 30, 2022	12.86M
March 31, 2022	11.87M
December 31, 2021	10.18M
September 30, 2021	8.802M
June 30, 2021	7.374M
March 31, 2021	6.554M
December 31, 2020	6.978M
September 30, 2020	7.051M
June 30, 2020	8.274M
March 31, 2020	9.136M
December 31, 2019	10.98M

Date	Value
September 30, 2019	22.20M
June 30, 2019	19.65M
March 31, 2019	17.66M
December 31, 2018	14.29M
September 30, 2018	6.740M
June 30, 2018	10.21M
March 31, 2018	13.99M
December 31, 2017	17.66M
September 30, 2017	16.53M
June 30, 2017	16.09M
March 31, 2017	15.20M
December 31, 2016	14.69M
September 30, 2016	14.13M
June 30, 2016	12.56M
March 31, 2016	11.03M
December 31, 2015	8.659M
September 30, 2015	6.233M
June 30, 2015	5.397M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

6.554M

Minimum

Mar 2021

22.20M

Maximum

Sep 2019

11.51M

Average

11.87M

Median

Mar 2022

SG&A Expense (TTM) Benchmarks